0001104659-23-052082.txt : 20230531 0001104659-23-052082.hdr.sgml : 20230531 20230428073602 ACCESSION NUMBER: 0001104659-23-052082 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230428 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carisma Therapeutics Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 2674916422 MAIL ADDRESS: STREET 1: 3675 MARKET STREET STREET 2: SUITE 200 CITY: PHILADELPHIA STATE: PA ZIP: 19104 FORMER COMPANY: FORMER CONFORMED NAME: Sesen Bio, Inc. DATE OF NAME CHANGE: 20180516 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 CORRESP 1 filename1.htm

 

CARISMA THERAPEUTICS INC.

3675 Market Street, Suite 200

Philadelphia, PA 19104

 

April 28, 2023

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re: Carisma Therapeutics Inc.
  Registration Statement on Form S-3
  File No. 333-271296
  Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Carisma Therapeutics Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-271296), so that it may become effective at 4:30 p.m. Eastern Time on May 2, 2023, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff.

 

  Very truly yours,
   
  CARISMA THERAPEUTICS INC.
     
  By: /s/ Steven Kelly 
  Name: Steven Kelly
  Title: President and Chief Executive Officer

 

cc: Brian A. Johnson
  Wilmer Cutler Pickering Hale and Dorr LLP